Back to results
US 10,239,825 B2Granted
Ketamine derivatives
AssigneeAuckland Uniservices Limited
InventorsJames Wallace Sleigh, William Alexander Denny, Jiney Jose, Swarnalatha Akuratiya Gamage, Martyn Gregory Harvey, Logan James Voss
Life of this patent
Estimating the term…
Abstract
The present invention relates to ketamine derivatives of the formula (I), pharmaceutical compositions comprising them, and methods for treating pain comprising administering them, and their use in the manufacture of medicaments for treating pain. The present invention also relates to methods for anaesthetizing and methods for sedating a subject comprising administering ketamine derivatives of the formula (II).
Claims24
A compound of formula (I):
- wherein
- Y1 is —C2-6alkylC(O)OR1, —C2-6alkylOC(O)R1, —C1-6-alkylC(O)OC1-6alkylC(O)OR1, or —C1-6alkylC(O)OC1-6alkylOR3, wherein each alkyl is optionally substituted with one or more R2;
- R1 is C1-6aliphatic, optionally substituted with one or more halo, CN, NO2, NH2, NHR11, NR11R12, C1-6haloalkyl, C1-6haloalkoxy, C(O)NH2, C(O)NHR11, C(O)NR11R12, SO2R11, OR11, C(O)R11, and C1-6aliphatic;
- R2 is C1-6aliphatic, optionally substituted with one or more halo, OR11, or CN;
- R3 is hydrogen or R1;
- R11 and R12 are each independently C1-6aliphatic;
- or R11 and R12 together with the nitrogen atom to which they are attached are a heteroaryl or heterocyclyl ring;
- Y2 is hydrogen or R2;
- X1 and X2 are each independently hydrogen, R2, halo, NO2, NH2, NHR11, NR11R12, C1-6haloalkyl, C1-6haloalkoxy, C(O)NH2, C(O)NHR11, C(O)NR11R12, SO2R11, OR11, C(O)R11, C1-6aliphaticY1, OY1, C(O)Y1, SO2Y1, or C(O)NHY1 at any of the available 2-5 positions;
- or a pharmaceutically acceptable salt or solvate thereof.
7 more elements
Dependencies are inferred from the claim text.